Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

108.80
-1.0500-0.96%
Pre-market: 108.46-0.3400-0.31%08:51 EDT
Volume:4.28M
Turnover:466.02M
Market Cap:135.34B
PE:23.00
High:110.15
Open:109.21
Low:108.16
Close:109.85
Loading ...

Gilead Sciences Inc. Chief Commercial Officer Johanna Mercier Reports Disposal of Common Shares

Reuters
·
24 May

Healthcare Stocks Are So Bad, They're Good. What to Buy Now. -- Barrons.com

Dow Jones
·
23 May

Gilead Sciences Says Trodelvy Met Primary Endpoint in Phase 3 Breast Cancer Trial

MT Newswires Live
·
23 May

BRIEF-ASCENT-03 - Trodelvy Demonstrates Highly Statistically Significant & Clinically Meaningful Improvement in Progression Free Survival in Patients With First-line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors

Reuters
·
23 May

Gilead announces ASCENT-03 study meets primary endpoint

TIPRANKS
·
23 May

Gilead Sciences Announces Breakthrough Phase 3 Results: Trodelvy Significantly Improves Survival in First-line Metastatic Triple-Negative Breast Cancer

Reuters
·
23 May

Gilead Sciences Inc - Trodelvy Safety Profile Consistent With Prior Studies in Ascent-03

THOMSON REUTERS
·
23 May

Gilead Sciences Inc - Ascent-03 Study Meets Primary Endpoint With Significant Improvement in Pfs

THOMSON REUTERS
·
23 May

Ascent-03: Trodelvy® Demonstrates Highly Statistically Significant & Clinically Meaningful Improvement in Progression Free Survival in Patients With First-Line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors

THOMSON REUTERS
·
23 May

Sector Update: Health Care Stocks Retreat Thursday Afternoon

MT Newswires Live
·
23 May

HOOKIPA to Sell HBV, HIV Program Assets to Gilead; Shares Rise

MT Newswires Live
·
23 May

Gilead put volume heavy and directionally bearish

TIPRANKS
·
22 May

Hookipa Pharma Sells Assets to Gilead Sciences

TIPRANKS
·
22 May

Hookipa Pharma Inc. Announces Asset Sale Agreement with Gilead Sciences for HB-400 and HB-500 Programs

Reuters
·
22 May

Yuhan Secures HIV API Supply Contract with Gilead Sciences

MT Newswires Live
·
22 May

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
22 May

Needham Sticks to Their Hold Rating for Gilead Sciences (GILD)

TIPRANKS
·
21 May

Gilead Sciences Inc. Stock Climbs 2.8%, Outperforms Competitors

Dow Jones
·
21 May

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-05-20

Reuters
·
21 May

Vaccine Stocks Surge with Moderna up 11%

Tiger Newspress
·
20 May